Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
SGRY

Surgery Partners (SGRY) stock: insider trades, news & valuation

Health Care · Net selling
Close · Oct 9, 2026 $13.89 +1.8% on the day -31.6% over 12 months 52-week range $11.49 – $22.94

Share price and insider trades

SGRY closeInsider buyInsider sale
10152025NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $24,865 on 2026-03-05 · William Trenton WebbSold $76,360 on 2026-03-12 · Jennifer BaldockSold $90,366 on 2026-03-13 · Danielle Burkhalter, Marissa BrittenhamBought $304,712 on 2026-08-18 · Teresa DelucaSold $365,226 on 2026-03-16 · David T Doherty, Jason Eric EvansSold $727,242 on 2026-03-06 · Danielle Burkhalter, David T Doherty, Jason Eric Evans, Jennifer Baldock, Marissa Brittenham, William Trenton Webb
Bought, 12 months$305K
Sold, 12 months$1.3M
Insiders buying1
Insiders selling6

Surgery Partners insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $305K and 6 sold $1.3M of SGRY stock on the open market.

SGRY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $1.3M sold (12 trades)Q1 2026Q2 2026Q3 2026: $305K bought (2 trades)$305KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$305K2—0
Q2 2026—0—0
Q1 2026—0$1.3M12

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$1.82BMedical Care Facilities
Profit margin-2.6%Revenue growth +2.7%
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit−$10KOn all tracked purchases -3.1%

Summary

Over the past 12 months, 1 Surgery Partners, Inc. insider reported open-market purchases totaling $305K, while 6 insiders reported sales totaling $1.3M. 0 of 12 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

SGRY stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 20SEC Teresa DelucaDirector Buy 11,25068,093 held (+20%) $14.33 $161K -3.1% —
Aug 19SEC Teresa DelucaDirector Buy 10,00066,843 held (+18%) $14.35 $144K -3.2% —
Mar 16SEC Jason Eric EvansCEO Sell 20,400920,386 held (−2%) $12.47 $254K +11.4% —
Mar 16SEC David T DohertyCFO Sell 8,867221,679 held (−4%) $12.50 $111K +11.1% —
Mar 16SEC Jennifer BaldockChief Admin & Dev Officer Sell 5,798326,474 held (−2%) $13.17 $76K +5.5% —
Mar 16SEC Marissa BrittenhamChief Strategy Officer Sell 3,65794,196 held (−4%) $12.54 $46K +10.8% —
Mar 16SEC Danielle BurkhalterChief Human Resources Officer Sell 3,46976,864 held (−4%) $12.83 $45K +8.3% —
Mar 9SEC David T DohertyCFO Sell 14,57488,803 held (−14%) $13.84 $202K +0.4% —
Mar 9SEC Jason Eric EvansCEO Sell 11,462662,680 held (−2%) $13.79 $158K +0.7% —
Mar 9SEC Jennifer BaldockChief Admin & Dev Officer Sell 10,082332,272 held (−3%) $13.70 $138K +1.4% —
Mar 9SEC Marissa BrittenhamChief Strategy Officer Sell 8,78554,623 held (−14%) $13.70 $120K +1.4% —
Mar 9SEC Danielle BurkhalterChief Human Resources Officer Sell 7,73637,103 held (−17%) $13.60 $105K +2.1% —
Mar 9SEC William Trenton WebbPresident Sell 1,79472,455 held (−2%) $13.86 $25K +0.2% —
Mar 9SEC William Trenton WebbPresident Sell 27274,249 held (−0%) $13.93 $4K -0.3% —

Insiders at Surgery Partners, Inc.

InsiderBoughtSoldLast filingScore
Teresa DelucaDirector $305K — Aug 20, 2026 —
Jason Eric EvansCEO — $412K Mar 16, 2026 —
David T DohertyCFO — $313K Mar 16, 2026 —
Jennifer BaldockChief Admin & Dev Officer — $214K Mar 16, 2026 —
Marissa BrittenhamChief Strategy Officer — $166K Mar 16, 2026 —
Danielle BurkhalterChief Human Resources Officer — $150K Mar 16, 2026 —
William Trenton WebbPresident — $29K Mar 9, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

SGRY stock: common questions

Are Surgery Partners, Inc. insiders buying SGRY stock?

In the past 12 months, 1 insiders reported open-market purchases of SGRY worth $305K. The latest was Director Teresa Deluca bought $161K of SGRY at $14.33 — largest purchase by this insider in our records.

Are Surgery Partners, Inc. insiders selling SGRY stock?

6 insiders reported sales worth $1.3M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is SGRY's 52-week range?

Over the past year SGRY has traded between $11.49 and $22.94. It last closed at $13.89 on Oct 9, 2026.